Daniel Morganstein

8PUBLICATIONS
61CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 22, 2025
Mortality Outcomes in People with Lung Cancer with and without Type2 Diabetes: A Cohort Study in England.

Eseosa Grace Igbinosa, Bodini Dharmasekara, Jennifer K Quint

|Jul 11, 2025
Using routinely collected patient data to study the impact of type 2 diabetes on breast cancer.

Ayaan Khurshed, Gema Hernandez, Gavin Soady

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Mar 08, 2023
Diagnostic criteria and proposed management of immune-related endocrinopathies following immune checkpoint inhibitor therapy for cancer.

Ruth Percik, Sherwin Criseno, Safwaan Adam

|Jan 25, 2023
Hyperglycaemia following immune checkpoint inhibitor therapy-Incidence, aetiology and assessment.

Kaenat Mulla, Sheima Farag, Benedict Moore

|Jun 24, 2022
Diabetes and cancer: Optimising glycaemic control.

Nalinie Joharatnam-Hogan, Daniel L Morganstein

Pageof 2

Frequent Collaborators

1 joint publications

Alessio Cortellini

1 joint publications

Antonio D'Alessio

1 joint publications

Siobhan Cleary

1 joint publications

Sebastiano Buti